StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3042% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson ZYTIGA [reported separately through FY2025Q4] by Quarter

ZYTIGA (abiraterone acetate) [reported separately through FY2025Q4] — International sales ($M) ($M)

QuarterlyAnnual

Johnson & Johnson ZYTIGA [reported separately through FY2025Q4]: $115M in Q4 2025, down 9.4% from a year earlier.

Latest, Q4 2025
115
Period ended Dec 28, 2025
Change on a year earlier
-9.4%
127 in Q4 2024
History
37 quarters
Since Q4 2016
Sources
29
Documents cited below

Where the Q4 2025 figure comes from

Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)

Source: Form 10-K (filed 2026-02-11) ↗

Reported in Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedZYTIGA (abiraterone acetate) [reported separately through FY2025Q4] — International sales ($M) ($M)Year on yearSource
Q4 2025Dec 28, 2025115-9.4%Form 10-K (filed 2026-02-11) ↗
Q3 2025Sep 28, 2025108-25.0%Form 10-Q (filed 2025-10-22) ↗
Q2 2025Jun 29, 2025139-9.7%Form 10-Q (filed 2025-07-24) ↗
Q1 2025Mar 30, 2025118-31.4%Form 10-Q (filed 2025-04-23) ↗
Q4 2024Dec 29, 2024127-33.5%Form 10-K (filed 2026-02-11) ↗
Q3 2024Sep 29, 2024144-27.6%Form 10-Q (filed 2025-10-22) ↗
Q2 2024Jun 30, 2024154-29.4%Form 10-Q (filed 2025-07-24) ↗
Q1 2024Mar 31, 2024172-24.9%Form 10-Q (filed 2025-04-23) ↗
Q4 2023Dec 31, 2023191-23.6%Form 10-K (filed 2026-02-11) ↗
Q3 2023Oct 1, 2023199-54.8%Form 10-Q (filed 2024-10-23) ↗
Q2 2023Jul 2, 2023218-55.1%Form 10-Q (filed 2024-07-25) ↗
Q1 2023Apr 2, 2023229-56.0%Form 10-Q (filed 2024-05-01) ↗
Q4 2022Jan 1, 2023250-52.4%Form 10-K (filed 2025-02-13) ↗
Q3 2022Oct 2, 2022440-15.9%Form 10-Q (filed 2023-10-27) ↗
Q2 2022Jul 3, 2022486-10.3%Form 10-Q (filed 2023-07-31) ↗
Q1 2022Apr 3, 2022520-11.6%Form 10-Q (filed 2023-04-28) ↗

Breakdown

What makes up ZYTIGA [reported separately through FY2025Q4]

Cite this data

StockData. (2026). Johnson & Johnson ZYTIGA [reported separately through FY2025Q4] ($M), quarterly Q4 2016–Q4 2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug-zytiga-intl

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.